Slides
Page 1
8 Protagonist Therapeutics 60 50 20 30 40 50 60 10 100 110 120 PTG - 300 PTG - 200 PN - 943 Rusfertide : Removal of FDA Clinical Hold Conference Call 10 October 11 , 2021
Loading workspace
8 Protagonist Therapeutics 60 50 20 30 40 50 60 10 100 110 120 PTG - 300 PTG - 200 PN - 943 Rusfertide : Removal of FDA Clinical Hold Conference Call 10 October 11 , 2021
Your watchlist and earnings event details are available after you sign in.